scispace - formally typeset
R

Regina Vogel

Researcher at Max Delbrück Center for Molecular Medicine

Publications -  11
Citations -  2287

Regina Vogel is an academic researcher from Max Delbrück Center for Molecular Medicine. The author has contributed to research in topics: Cancer & Breast cancer. The author has an hindex of 6, co-authored 9 publications receiving 2088 citations.

Papers
More filters
Journal ArticleDOI

beta-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin.

TL;DR: It is shown that beta-catenin is required genetically downstream of tabby/downless and upstream of bmp and shh in placode formation and is essential for fate decisions of skin stem cells: in the absence of beta-Catenin, stem cells fail to differentiate into follicular keratinocytes, but instead adopt an epidermal fate.
Journal ArticleDOI

Requirement for beta-catenin in anterior-posterior axis formation in mice.

TL;DR: The data demonstrate that β-catenin function is essential in anterior-posterior axis formation in the mouse, and experiments with chimeric embryos show that this function is required in the embryonic ectoderm.
Journal ArticleDOI

Cancer Stem Cells Regulate Cancer-Associated Fibroblasts via Activation of Hedgehog Signaling in Mammary Gland Tumors.

TL;DR: The results identify a novel intracellular signaling module that synergistically regulates CAFs and CSCs in mammary gland tumors driven by combined activation of Wnt/β-catenin and Hgf/Met signaling in mouse mammary epithelial cells.
Journal ArticleDOI

Distinct requirements for Gab1 in Met and EGF receptor signaling in vivo.

TL;DR: It is demonstrated that Gab1 induces different biological responses through the recruitment of distinct effectors and that different modes of recruitment for Gab1 are required in different organs.
Journal ArticleDOI

Combined Wnt/β-catenin, Met, and CXCL12/CXCR4 signals characterize basal breast cancer and predict disease outcome.

TL;DR: A compound-mutant mouse model combining the activation of β-catenin and HGF (Wnt-Met signaling) produced rapidly growing basal mammary gland tumors, and targeting CXCR4 and its upstream activators, Wnt and Met, might provide an efficient strategy for breast cancer treatment.